IFP Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

IFP Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	-$18K	–	4192
2016 Q3	$18K	Buy	+500	New	+$10.7K	﹤0.01%	2485

Other funds holding CLVS

RMC

Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

IFP Advisors's CLVS Position: Q1 2023 in Review

IFP Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 10,050 shares — an estimated $479K sold.

IFP Advisors first reported a position in CLVS in Q4 2015 and held it in 15 quarters. The position peaked at $479K in Q4 2022. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

IFP Advisors reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
IFP Advisors sold 10,050 Clovis Oncology, Inc. shares in Q1 2023, an estimated $479K.
IFP Advisors first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 15 quarters.
IFP Advisors's Clovis Oncology, Inc. position peaked at $479K in Q4 2022.
2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.